Zydus Lifesciences Limited
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Zydus Lifesciences Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $150,629,000,000. Profit margin reached 12%. Total operating expenses were $34,690,000,000.
Profit Margin
| 2010 | 36.86B | 5.05B | 13.7% |
|---|---|---|---|
| 2011 | 44.64B | 7.11B | 15.92% |
| 2012 | 50.9B | 6.52B | 12.82% |
| 2015 | 86.51B | 11.48B | 13.28% |
| 2016 | 98.37B | 15.22B | 15.48% |
| 2018 | 115.99B | 17.75B | 15.31% |
| 2019 | 129.28B | 18.48B | 14.3% |
| 2021 | 142.87B | 21.33B | 14.93% |
| 2022 | 150.62B | 18.06B | 11.99% |
CADILAHC.NS Income Statement (2010 – 2021)
| 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 150.62B | 142.87B | 129.28B | 115.99B | 98.37B | 86.51B | 50.9B | 44.64B | 36.86B |
Cost of revenue | 91.68B | 82.17B | 78.46B | 43.42B | 34.59B | 33.09B | 20.55B | 14.75B | 11.78B |
Gross profit | 58.94B | 60.69B | 50.82B | 72.56B | 63.77B | 53.41B | 30.34B | 29.89B | 25.08B |
Operating exp. | |||||||||
Research and development | 10.40B | 11.19B | 9.51B | 1.68B | 1.38B | 1.09B | 0 | 2.50B | 1.66B |
Selling and marketing | 0 | 13.88B | 10.35B | 10.14B | 10.20B | 9.60B | 0 | 0 | 0 |
Total operating expenses | 34.69B | 34.40B | 28.80B | 49.56B | 42.93B | 38.52B | 24.31B | 20.76B | 18.17B |
Operating income | 24.25B | 26.28B | 22.02B | 23.00B | 20.84B | 14.88B | 6.02B | 9.12B | 6.90B |
Other income (expenses), net | 4.12B | -2.29B | 1.80B | 1.21B | 390M | -434M | 1.91B | 699M | 867M |
Income before tax | 28.38B | 23.99B | 23.82B | 23.30B | 21.23B | 14.45B | 7.94B | 8.42B | 6.03B |
Income tax expense | 5.11B | 1.93B | 5.30B | 5.64B | 5.71B | 2.59B | 1.13B | 1.06B | 741M |
Net income | 18.06B | 21.33B | 18.48B | 17.75B | 15.22B | 11.48B | 6.52B | 7.11B | 5.05B |
Earnings per share | |||||||||
Basic EPS | 17.65 | 20.84 | 18.06 | 17.35 | 14.87 | 11.22 | 6.37 | 6.94 | 4.97 |
Diluted EPS | 17.65 | 20.84 | 18.06 | 17.35 | 14.87 | 11.22 | 6.37 | 6.94 | 4.97 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |